Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors for diseases involving dysfunctional metabolic and fibrotic pathways. The company's drug candidates are in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne, and select forms of cancer.
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.